Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fecal Microbiome Transplantation in Cirrhosis: Randomized, Double-blinded, Placebo-Controlled Trial in Patients With Decompensated Cirrhosis

NCT06533852 is registered in ClinicalTrials.gov with Consorcio Centro de Investigación Biomédica en Red (CIBER) as lead sponsor.

NCT NCT06533852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06533852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fecal Microbiome Transplantation in Cirrhosis: Randomized, Double-blinded, Placebo-Controlled Trial in Patients With Decompensated Cirrhosis
Lead sponsor
Consorcio Centro de Investigación Biomédica en Red (CIBER)
Phase
Phase 3
Overall status
Recruiting
Start date
July 16, 2025
Completion date
January 31, 2029
Enrollment
190 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

decompensated cirrhosis